Jensen S M, Gazdar A F, Cuttitta F, Russell E K, Linnoila R I
National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.
Cancer Res. 1990 Sep 15;50(18):6068-74.
Synaptophysin is a Mr 38,000 integral membrane glycoprotein expressed by a variety of normal and neoplastic neuroendocrine cells. We studied synaptophysin as an immunocytochemical marker for neuroendocrine differentiation in lung cancer and compared it to the immunocytochemical expression of chromogranin A, a marker for dense core (endocrine) granules, and the biochemical activity of L-dopa decarboxylase (DDC), the key amine-handling enzyme. Of the 250 cell lines available to us, we selected examples representative of the following cell types: bronchial carcinoids (n = 4), small cell lung cancer (SCLC) (n = 7), extrapulmonary small cell carcinomas (n = 4), and non-small cell lung cancers (n = 18) whose neuroendocrine status had been previously determined on the basis of electron microscopy and DDC activity. We demonstrated (a) there was a higher incidence of synaptophysin than chromogranin A immunoreactivity in carcinoid (100 versus 75%), classic SCLC (70 versus 50%), and variant SCLC (57 versus 29%) cell lines; (b) 3 of the 4 (75%) extrapulmonary small cell lung cancer cell lines expressed synaptophysin and chromogranin A; (c) 5 of the 7 (71%) non-small cell lung cancer cell lines previously shown to express multiple neuroendocrine markers were positive for synaptophysin, chromogranin A, and DDC activity; (d) none of the other 11 non-small cell lung cancer cell lines expressed synaptophysin or chromogranin A; and (e) formalin fixation and paraffin embedding reduced synaptophysin immunoreactivity in 11 of 14 (79%) of the cell lines, as compared to freshly prepared specimens fixed in 95% ethanol. Western blot analysis using the synaptophysin antibody (SY38) demonstrated immunoreactive proteins ranging from Mr 43,000 to 45,000 in five representative cell lines. The concordance of expression of all three neuroendocrine markers was statistically significant when values for all cell lines were totalled. Synaptophysin was a more commonly expressed marker for variant SCLC cell lines, which rarely showed DDC activity. We conclude that synaptophysin may be a more sensitive and specific marker for neuroendocrine differentiation, when compared to chromogranin A and DDC in lung cancer cell lines which express only part of the neuroendocrine program.
突触素是一种分子量为38000的整合膜糖蛋白,由多种正常和肿瘤性神经内分泌细胞表达。我们研究了突触素作为肺癌神经内分泌分化的免疫细胞化学标志物,并将其与嗜铬粒蛋白A的免疫细胞化学表达(一种致密核心(内分泌)颗粒的标志物)以及L-多巴脱羧酶(DDC)的生化活性(关键的胺处理酶)进行了比较。在我们可获得的250个细胞系中,我们选择了代表以下细胞类型的实例:支气管类癌(n = 4)、小细胞肺癌(SCLC)(n = 7)、肺外小细胞癌(n = 4)以及非小细胞肺癌(n = 18),其神经内分泌状态先前已根据电子显微镜和DDC活性确定。我们证明:(a)在类癌(100%对75%)、经典SCLC(70%对50%)和变异型SCLC(57%对29%)细胞系中,突触素免疫反应性的发生率高于嗜铬粒蛋白A;(b)4个肺外小细胞肺癌细胞系中的3个(75%)表达突触素和嗜铬粒蛋白A;(c)先前显示表达多种神经内分泌标志物的7个非小细胞肺癌细胞系中的5个(71%)对突触素、嗜铬粒蛋白A和DDC活性呈阳性;(d)其他11个非小细胞肺癌细胞系均未表达突触素或嗜铬粒蛋白A;(e)与新鲜制备的用95%乙醇固定的标本相比,福尔马林固定和石蜡包埋使14个细胞系中的11个(79%)的突触素免疫反应性降低。使用突触素抗体(SY38)的蛋白质印迹分析在五个代表性细胞系中显示了分子量在43000至45000之间的免疫反应性蛋白。当将所有细胞系的值相加时,所有三种神经内分泌标志物表达的一致性具有统计学意义。突触素是变异型SCLC细胞系中更常表达的标志物,这些细胞系很少显示DDC活性。我们得出结论,与仅表达部分神经内分泌程序的肺癌细胞系中的嗜铬粒蛋白A和DDC相比,突触素可能是神经内分泌分化更敏感和特异的标志物。